Overview
Study information
| Network: | HVTN |
| Grant Affiliation: | NA |
| Strategy: | NA |
| Study Type: | Phase I |
| Species: | Human |
| Stage: | Primary analysis complete |
| Study Start Date: | NA |
| Study Made Public: | NA |
Title
A Phase I clinical trial to evaluate the safety and immunogenicity of a Clade B gag DNA/PLG and env DNA/PLG microparticles vaccine and a Clade B recombinant, oligomeric gp140/MF59 adjuvant vaccine in healthy, HIV 1 uninfected adult participants
Description
HVTN 049 is a Phase I clinical trial to evaluate the safety and immunogenicity of Clade B gag DNA/PLG and env DNA/PLG microparticles vaccine and a Clade B recombinant, oligomeric gp140/MF59 adjuvant.
Sign in to see full information about this study and to download study data.
Products
Product info coming soon!Integrated data
No integrated data is available for this study.
Non-integrated data
No non-integrated data is available for this study.